104 related articles for article (PubMed ID: 6671927)
1. Activity of trimethoprim (TMP), sulphamethoxazole (SMX) and the combination against Bacteroides fragilis group isolates.
Jackson-York GL; Gump BB; Gump DW
J Antimicrob Chemother; 1983 Nov; 12(5):515-8. PubMed ID: 6671927
[TBL] [Abstract][Full Text] [Related]
2. Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis.
Phillips I; Warren C
Antimicrob Agents Chemother; 1976 May; 9(5):736-40. PubMed ID: 949171
[TBL] [Abstract][Full Text] [Related]
3. Activity of sulfamethoxazole trimethoprim against Bacteroides fragilis.
Nadaud M
Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):79-84. PubMed ID: 735555
[TBL] [Abstract][Full Text] [Related]
4. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
Rosenblatt JE; Stewart PR
Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
Crider SR; Colby SD
Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of anaerobes to co-trimoxazole.
Wüst J
Infection; 1980; 8 Suppl 2():S187-9. PubMed ID: 7450860
[TBL] [Abstract][Full Text] [Related]
7. Prevention of pleuropneumonia in pigs by in-feed medication with sulphadimethoxine and sulphamethoxazole in combination with trimethoprim.
Mengelers MJ; Kuiper HA; Pijpers A; Verheijden JH; van Miert AS
Vet Q; 2000 Jul; 22(3):157-62. PubMed ID: 10952447
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
Rawal BD; Cottis L
Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
[TBL] [Abstract][Full Text] [Related]
9. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
10. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.
Guerrant RL; Wood SJ; Krongaard L; Reid RA; Hodge RH
Antimicrob Agents Chemother; 1981 Jan; 19(1):33-8. PubMed ID: 7247360
[TBL] [Abstract][Full Text] [Related]
11. Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.
Then RL; Angehrn P
Antimicrob Agents Chemother; 1979 Jan; 15(1):1-6. PubMed ID: 218496
[TBL] [Abstract][Full Text] [Related]
12. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.
Najjar A; Murray BE
Antimicrob Agents Chemother; 1987 May; 31(5):808-10. PubMed ID: 3111362
[TBL] [Abstract][Full Text] [Related]
13. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
Murray BE; Rensimer ER; DuPont HL
N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
Unal S; Aydin M; Akin A
Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
Wong CK; Harding GK; Ronald AR; Hoban S
Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
[TBL] [Abstract][Full Text] [Related]
16. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
Pancoast SJ; Hyams DM; Neu HC
Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
[TBL] [Abstract][Full Text] [Related]
17. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
Kamme C; Melander A; Nilsson NI
Scand J Infect Dis; 1983; 15(1):107-13. PubMed ID: 6342125
[TBL] [Abstract][Full Text] [Related]
18. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
Vilchèze C; Jacobs WR
Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
[TBL] [Abstract][Full Text] [Related]
19. Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.
Rosenblatt JE; Stewart PR
Antimicrob Agents Chemother; 1974 Jul; 6(1):84-92. PubMed ID: 15828175
[TBL] [Abstract][Full Text] [Related]
20. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli.
Greenwood D; O'Grady F
J Clin Pathol; 1976 Feb; 29(2):162-6. PubMed ID: 777036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
